{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T21:07:17Z","timestamp":1784408837475,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,21]]},"DOI":"10.7759\/cureus.84583","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T02:53:08Z","timestamp":1747882388000},"source":"Crossref","is-referenced-by-count":1,"title":["Novel Combination Therapy With Lenalidomide and Trametinib for Treatment-Resistant Xanthoma Disseminatum With Disabling Cutaneous and Synovial Involvement: A Case Report"],"prefix":"10.7759","author":[{"given":"Sundeep","family":"Bekal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifaa","family":"Abdulhaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Xanthoma disseminatum: report of one case","volume":"12","author":"Kong W","year":"2019","unstructured":"Kong W, Liu Z, Zhang S. Xanthoma disseminatum: report of one case. Int J Clin Exp Pathol. 2019, 12:4349-53.","journal-title":"Int J Clin Exp Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1938.01480090002001","article-title":"Xanthomatosis: correlation of clinical, histopathologic and chemical studies of cutaneous xanthoma","volume":"37","author":"Montgomery H","year":"1938","unstructured":"Montgomery H, Osterberg AE. Xanthomatosis: correlation of clinical, histopathologic and chemical studies of cutaneous xanthoma. Arch Derm Syphilol. 1938, 37:373-402. 10.1001\/archderm.1938.01480090002001","journal-title":"Arch Derm Syphilol"},{"key":"ref3","article-title":"Andrews' Diseases of the Skin: Clinical Dermatology","author":"Odom RB","year":"2000","unstructured":"Odom RB, James WD, Berger TG. Andrews' Diseases of the Skin: Clinical Dermatology. WB Saunders Company, Philadelphia, PA; 2000."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-019-2005-z","article-title":"Osteoarticular lesion in xanthoma disseminatum treated with total hip arthroplasty: a case report","volume":"13","author":"Taniguchi Y","year":"2019","unstructured":"Taniguchi Y, Nishino T, Sugaya H, Hajime M, Ochiai N, Yamazaki M. Osteoarticular lesion in xanthoma disseminatum treated with total hip arthroplasty: a case report. J Med Case Rep. 2019, 13:51. 10.1186\/s13256-019-2005-z","journal-title":"J Med Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009399","article-title":"Xanthomatosis in bilateral hands mimicking rheumatoid arthritis: A case report","volume":"96","author":"Li D","year":"2017","unstructured":"Li D, You L, Fan S, Tan L. Xanthomatosis in bilateral hands mimicking rheumatoid arthritis: A case report. Medicine (Baltimore). 2017, 96:e9399. 10.1097\/MD.0000000000009399","journal-title":"Medicine (Baltimore)"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.2106\/00004623-196042070-00007","article-title":"Pigmented villonodular synovitis with invasion of bone: report of six cases","volume":"42","author":"McMaster PE","year":"1960","unstructured":"McMaster PE. Pigmented villonodular synovitis with invasion of bone: report of six cases. J Bone Joint Surg Am. 1960, 42:1170-83.","journal-title":"J Bone Joint Surg Am"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.23116","article-title":"A novel colony-stimulating factor 1 (CSF1) translocation involving human endogenous retroviral element in a tenosynovial giant cell tumor","volume":"62","author":"Lipplaa A","year":"2023","unstructured":"Lipplaa A, Meijer D, van de Sande MA, Gelderblom H, Bov\u00e9e JV, Mei H, Szuhai K. A novel colony-stimulating factor 1 (CSF1) translocation involving human endogenous retroviral element in a tenosynovial giant cell tumor. Genes Chromosomes Cancer. 2023, 62:223-30. 10.1002\/gcc.23116","journal-title":"Genes Chromosomes Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-147017","article-title":"ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy","volume":"112","author":"Chan JK","year":"2008","unstructured":"Chan JK, Lamant L, Algar E, et al.. ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy. Blood. 2008, 112:2965-8. 10.1182\/blood-2008-03-147017","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12388","article-title":"Xanthoma disseminatum associated with inflammatory arthritis and synovitis--a rare association","volume":"32","author":"Gupta P","year":"2015","unstructured":"Gupta P, Khandpur S, Vedi K, Singh MK, Walia R. Xanthoma disseminatum associated with inflammatory arthritis and synovitis--a rare association. Pediatr Dermatol. 2015, 32:e1-4. 10.1111\/pde.12388","journal-title":"Pediatr Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130977","article-title":"BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups","volume":"211","author":"Berres ML","year":"2014","unstructured":"Berres ML, Lim KP, Peters T, et al.. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. J Exp Med. 2014, 211:669-83. 10.1084\/jem.20130977","journal-title":"J Exp Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very G","year":"2010","unstructured":"Badalian-Very G, Vergilio JA, Degar BA, et al.. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010, 116:1919-23. 10.1182\/blood-2010-04-279083","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-05-430140","article-title":"High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses","volume":"120","author":"Haroche J","year":"2012","unstructured":"Haroche J, Charlotte F, Arnaud L, et al.. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 2012, 120:2700-3. 10.1182\/blood-2012-05-430140","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1012-y","article-title":"Efficacy of MEK inhibition in patients with histiocytic neoplasms","volume":"567","author":"Diamond EL","year":"2019","unstructured":"Diamond EL, Durham BH, Ulaner GA, et al.. Efficacy of MEK inhibition in patients with histiocytic neoplasms. Nature. 2019, 567:521-4. 10.1038\/s41586-019-1012-y","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009013","article-title":"Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis","volume":"7","author":"Aaroe A","year":"2023","unstructured":"Aaroe A, Kurzrock R, Goyal G, et al.. Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis. Blood Adv. 2023, 7:3984-92. 10.1182\/bloodadvances.2022009013","journal-title":"Blood Adv"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1993.tb02262.x","article-title":"Remission of Langerhans cell histiocytosis with thalidomide treatment","volume":"18","author":"Misery L","year":"1993","unstructured":"Misery L, Larbre B, Lyonnet S, Faure M, Thivolet J. Remission of Langerhans cell histiocytosis with thalidomide treatment. Clin Exp Dermatol. 1993, 18:487. 10.1111\/j.1365-2230.1993.tb02262.x","journal-title":"Clin Exp Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20578","article-title":"A phase II trial using thalidomide for Langerhans cell histiocytosis","volume":"48","author":"McClain KL","year":"2007","unstructured":"McClain KL, Kozinetz CA. A phase II trial using thalidomide for Langerhans cell histiocytosis. Pediatr Blood Cancer. 2007, 48:44-9. 10.1002\/pbc.20578","journal-title":"Pediatr Blood Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2008.00920.x","article-title":"Lenalidomide in the treatment of multiple myeloma: a review","volume":"33","author":"Armoiry X","year":"2008","unstructured":"Armoiry X, Aulagner G, Facon T. Lenalidomide in the treatment of multiple myeloma: a review. J Clin Pharm Ther. 2008, 33:219-26. 10.1111\/j.1365-2710.2008.00920.x","journal-title":"J Clin Pharm Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04719-1","article-title":"Successful treatment of multisystemic Rosai-Dorfman disease with lenalidomide and dexamethasone: a case report","volume":"101","author":"Liu T","year":"2022","unstructured":"Liu T, Cao X. Successful treatment of multisystemic Rosai-Dorfman disease with lenalidomide and dexamethasone: a case report. Ann Hematol. 2022, 101:1351-3. 10.1007\/s00277-021-04719-1","journal-title":"Ann Hematol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2021.09.010","article-title":"Improvement of primary vulvar Langerhans cell histiocytosis with lenalidomide","volume":"7","author":"Morrison S","year":"2021","unstructured":"Morrison S, Gray A, Greiling TM. Improvement of primary vulvar Langerhans cell histiocytosis with lenalidomide. Int J Womens Dermatol. 2021, 7:838-40. 10.1016\/j.ijwd.2021.09.010","journal-title":"Int J Womens Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2002.01680_1.x","article-title":"Xanthoma disseminatum","volume":"41","author":"Rupec RA","year":"2002","unstructured":"Rupec RA, Schaller M. Xanthoma disseminatum. Int J Dermatol. 2002, 41:911-3. 10.1046\/j.1365-4362.2002.01680_1.x","journal-title":"Int J Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2008.04036.x","article-title":"Xanthoma disseminatum with koebnerized pearly penile lesions in an Indian man","volume":"48","author":"Ghorpade A","year":"2009","unstructured":"Ghorpade A. Xanthoma disseminatum with koebnerized pearly penile lesions in an Indian man. Int J Dermatol. 2009, 48:996-8. 10.1111\/j.1365-4632.2008.04036.x","journal-title":"Int J Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.378","article-title":"Xanthoma disseminatum: effective therapy with 2-chlorodeoxyadenosine in a case series","volume":"147","author":"Khezri F","year":"2011","unstructured":"Khezri F, Gibson LE, Tefferi A. Xanthoma disseminatum: effective therapy with 2-chlorodeoxyadenosine in a case series. Arch Dermatol. 2011, 147:459-64. 10.1001\/archdermatol.2010.378","journal-title":"Arch Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0151-9638(04)93591-0","article-title":"Vinblastine treatment for extensive non-X histiocytosis (xanthoma disseminatum) [article in French]","volume":"131","author":"Pruvost C","year":"2004","unstructured":"Pruvost C, Picard-Dahan C, Bonnefond B, et al.. Vinblastine treatment for extensive non-X histiocytosis (xanthoma disseminatum) [article in French]. Ann Dermatol Venereol. 2004, 131:271-3. 10.1016\/s0151-9638(04)93591-0","journal-title":"Ann Dermatol Venereol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-186973","article-title":"Disseminated xanthogranuloma with BRAF gene fusion and profound response to MEK inhibitor therapy","volume":"142","author":"Lytvynova O","year":"2023","unstructured":"Lytvynova O, Vachhani HR, Farhat F, et al.. Disseminated xanthogranuloma with BRAF gene fusion and profound response to MEK inhibitor therapy. Blood. 2023, 142:6429. 10.1182\/blood-2023-186973","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/193917-novel-combination-therapy-with-lenalidomide-and-trametinib-for-treatment-resistant-xanthoma-disseminatum-with-disabling-cutaneous-and-synovial-involvement-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T02:53:09Z","timestamp":1747882389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/193917-novel-combination-therapy-with-lenalidomide-and-trametinib-for-treatment-resistant-xanthoma-disseminatum-with-disabling-cutaneous-and-synovial-involvement-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.84583","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,21]]}}}